Tirzepatide

Tirzepatide 5 mg — the dual incretin agonist that redefined metabolic research.
Tirzepatide is the first widely studied single molecule to engage two incretin receptor systems at once, and its arrival reshaped how laboratories approach glucose and energy balance research. Supplied as a 5 mg lyophilised vial, batch-tested and sealed.

What is Tirzepatide?

Tirzepatide is a synthetic 39-amino-acid peptide engineered as a dual agonist at both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. Its backbone is based on the native GIP sequence, modified with non-natural amino acids for protease resistance and carrying a C20 fatty diacid chain that promotes albumin binding and extends circulating half-life. What makes it mechanistically significant is that GIP and GLP-1 signalling had historically been studied as separate incretin arms; a single molecule engaging both provides researchers with a direct way to examine how the two pathways interact rather than inferring it from co-administration.

Research interest

• Dual incretin signalling — investigated for GIP and GLP-1 receptor crosstalk within a single construct.
• Glucose metabolism — studied in models examining insulin secretion and glycaemic regulation.
• Insulin sensitivity — of interest to researchers examining peripheral substrate handling in preclinical systems.
• Energy balance and body composition — applied in metabolic research on appetite and weight regulation.
• Peptide engineering — a reference example of non-natural amino acid substitution plus fatty-acid conjugation.

Specifications

• Content: 5 mg of active peptide per vial
• Form: Lyophilised powder (sealed vial)
• Purity: Pharmaceutical-grade, batch-tested
• Storage: 2–8 °C sealed and dry; −20 °C for long-term, protected from light

Handling & storage

A 39-residue lipidated peptide is sensitive to handling that shorter sequences tolerate. Keep the vial sealed, cold and dry, and equilibrate it to room temperature before opening so moisture does not condense onto the cake. Reconstitute under the receiving laboratory's validated protocol, adding solvent slowly down the inner wall and allowing the cake to dissolve passively; do not vortex or shake, since the fatty-acid chain makes the molecule surface-active and prone to foaming and aggregation at air–liquid interfaces. Verify a clear, particulate-free solution before use. Hold reconstituted material refrigerated and dark in low-binding single-use aliquots, and avoid repeated freeze–thaw cycling.

Why source from Rogue

• Verified purity — batch-tested material with documented identity and assay results.
• European supply chain — factory-sealed vials held in controlled conditions, never repackaged or grey-market.
• Discreet, tracked delivery — rapid EU-wide dispatch in unbranded, protective outer packaging.

For research purposes only. Not a medicinal product. Not for human or veterinary consumption. Intended for qualified laboratory research use only.

Related: Peptides · GHRP-6 10 mg · DSIP 5 mg · Retatrutide